These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 4694139)

  • 1. Agranulocytosis during dapsone administration.
    Ten Broeke JE; Cunningham LD
    Dermatologica; 1973; 146(1):21-4. PubMed ID: 4694139
    [No Abstract]   [Full Text] [Related]  

  • 2. [Agranulocytosis induced by dapsone prescribed for dermatitis herpetiformis].
    Machet L; Callens A; Mercier E; Gargot S; Lorette G; Vaillant L
    Ann Dermatol Venereol; 1996; 123(5):328-30. PubMed ID: 8761086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The incidence of agranulocytosis during treatment of dermatitis herpetiformis with dapsone as reported in Sweden, 1972 through 1988.
    Hörnsten P; Keisu M; Wiholm BE
    Arch Dermatol; 1990 Jul; 126(7):919-22. PubMed ID: 2360840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proliferation of IgD kappa plasma cells after agranulocytosis induced by dapsone.
    Lahuerta-Palacios JJ; Gomez-Pedraja JF; Montalban MA; Shandas GJ; Gomez-Salazar MD
    Br Med J (Clin Res Ed); 1985 Jan; 290(6464):282-3. PubMed ID: 3917786
    [No Abstract]   [Full Text] [Related]  

  • 5. Acetylator phenotype, minimal maintenance dose and haemolytic effect of dapsone in dermatitis herpetiformis.
    Förström L; Mattila MJ; Mustakallio KK
    Ann Clin Res; 1974 Oct; 6(5):308-10. PubMed ID: 4447343
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapeutic use of dapsone in dermatitis herpetiformis (Duhring) and in certain inflammatory skin diseases].
    Révész K; Schneider I
    Orv Hetil; 1995 Jan; 136(2):59-62. PubMed ID: 7862431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dapsone and severe hypoalbuminaemia in dermatitis herpetiformis.
    Cowan RE; Wright JT
    Br J Dermatol; 1981 Feb; 104(2):201-4. PubMed ID: 7213552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High dose dapsone toxicity.
    Shelley WB; Goldwein MI
    Br J Dermatol; 1976 Jul; 95(1):79-82. PubMed ID: 952745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment and management of dermatitis herpetiformis.
    Leonard JN; Fry L
    Clin Dermatol; 1991; 9(3):403-8. PubMed ID: 1806228
    [No Abstract]   [Full Text] [Related]  

  • 10. [Polyneuropathy in Duhring dermatitis herpetiformis].
    Dillmann U; Krämer G; Goebel HH
    Nervenarzt; 1991 Aug; 62(8):516-8. PubMed ID: 1944718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurotoxicity of sulfones.
    Hubler WR; Solomon H
    Arch Dermatol; 1972 Oct; 106(4):598. PubMed ID: 4342845
    [No Abstract]   [Full Text] [Related]  

  • 12. Fine points in the management of dermatitis herpetiformis.
    Fry L
    Semin Dermatol; 1988 Sep; 7(3):206-11. PubMed ID: 3153446
    [No Abstract]   [Full Text] [Related]  

  • 13. Manic depression induced by dapsone in patient with dermatitis herpetiformis.
    Gawkrodger D
    BMJ; 1989 Sep; 299(6703):860. PubMed ID: 2510873
    [No Abstract]   [Full Text] [Related]  

  • 14. Dapsone-mediated agranulocytosis: risks, possible mechanisms and prevention.
    Coleman MD
    Toxicology; 2001 Apr; 162(1):53-60. PubMed ID: 11311458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible dapsone-induced peripheral neuropathy in dermatitis herpetiformis.
    du Vivier A; Fowler T
    Proc R Soc Med; 1974 Jun; 67(6 Pt 1):439-40. PubMed ID: 4369028
    [No Abstract]   [Full Text] [Related]  

  • 16. Agranulocytosis--a case report.
    Rahman J; Chowdhury SA; Wajed J
    Bangladesh Med Res Counc Bull; 2000 Aug; 26(2):65-8. PubMed ID: 11508074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypersensitivity reaction to dapsone: report from Malaysia.
    Mohamed KN
    Lepr Rev; 1984 Dec; 55(4):385-9. PubMed ID: 6527602
    [No Abstract]   [Full Text] [Related]  

  • 18. [Long-term use of DDS by patients with Duhring's herpetiform dermatitis].
    Plechistova LA; Salikhov AS
    Vestn Dermatol Venerol; 1981 Sep; (9):74-6. PubMed ID: 7303890
    [No Abstract]   [Full Text] [Related]  

  • 19. Discontinuing dapsone treatment and reintroducing dietary gluten in patients with dermatitis herpetiformis in remission: comment on "remission in dermatitis herpetiformis".
    Mostow EN
    Arch Dermatol; 2011 Mar; 147(3):305-6. PubMed ID: 21422338
    [No Abstract]   [Full Text] [Related]  

  • 20. Agranulocytosis caused by dapsone therapy for granuloma annulare.
    Potter MN; Yates P; Slade R; Kennedy CT
    J Am Acad Dermatol; 1989 Jan; 20(1):87-8. PubMed ID: 2643642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.